Intas Pharma signs licensing pact with mAbxience for etanercept biosimilar
Intas gains exclusive commercialisation rights for Etanercept biosimilar for more than 150 countries worldwide
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
autoimmune diseases
AbbVie and Cugene announce collaboration in autoimmune diseases
Under the terms of the agreement, Cugene will receive an upfront payment of $48.5 million, and will also be eligible to receive…
Niramaya Research launches Research India initiative to promote medical research
Students from all Allopathic, Ayurvedic, Homeopathic, Dental Colleges in India can participate
J&J to buy Momenta in $6.5 bn deal
The acquisition will bolster J&J’s portfolio of drugs for autoimmune diseases